| Duoc T Nguyen, MD | |
|
3400 Delta Fair Blvd, Antioch, CA 94509-4004 | |
| (925) 779-5000 | |
| Not Available |
| Full Name | Duoc T Nguyen |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 29 Years |
| Location | 3400 Delta Fair Blvd, Antioch, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609954791 | NPI | - | NPPES |
| 00A564150 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A56415 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Permanente Medical Group Inc | 8921910225 | 7800 |
News Archive
A team led by a University of Arizona researcher has discovered a previously unknown mechanism that prevents the immune system from going into overdrive, shedding light not only on how our body controls its response to pathogens but on conditions such as autoimmune diseases, allergies and chronic inflammation as well.
Following today's introduction of a health care reform plan by Senate Finance Committee Chairman Max Baucus (D-MT), Joe Jackson, chairman of Save Flexible Spending Plans and CEO of WageWorks, a benefits company based in San Mateo, California, issued the following statement:
A new survey released today by the American Pain Foundation (APF) reveals that breakthrough cancer pain — sudden, temporary flares of severe pain that occur even when pain medication is used — is one of the most challenging aspects of having cancer, according to three out of four (75 percent) U.S. adults who have ever been diagnosed with cancer and experience this type of pain.
By analyzing the molecular details of how artificially created drug-resistant flu strains manage to survive treatment, St. Jude Children's Research Hospital scientists have developed insights to guide development of powerful new anti-influenza drugs. These compounds will target a viral enzyme critical to the virus' proliferation in the body.
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health. The experimental agent, known as AR-42 while in testing, was developed and tested in preclinical studies at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
› Verified 9 days ago
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
A team led by a University of Arizona researcher has discovered a previously unknown mechanism that prevents the immune system from going into overdrive, shedding light not only on how our body controls its response to pathogens but on conditions such as autoimmune diseases, allergies and chronic inflammation as well.
Following today's introduction of a health care reform plan by Senate Finance Committee Chairman Max Baucus (D-MT), Joe Jackson, chairman of Save Flexible Spending Plans and CEO of WageWorks, a benefits company based in San Mateo, California, issued the following statement:
A new survey released today by the American Pain Foundation (APF) reveals that breakthrough cancer pain — sudden, temporary flares of severe pain that occur even when pain medication is used — is one of the most challenging aspects of having cancer, according to three out of four (75 percent) U.S. adults who have ever been diagnosed with cancer and experience this type of pain.
By analyzing the molecular details of how artificially created drug-resistant flu strains manage to survive treatment, St. Jude Children's Research Hospital scientists have developed insights to guide development of powerful new anti-influenza drugs. These compounds will target a viral enzyme critical to the virus' proliferation in the body.
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health. The experimental agent, known as AR-42 while in testing, was developed and tested in preclinical studies at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Duoc T Nguyen, MD 1800 Harrison St Fl 7, Oakland, CA 94612-3466 Ph: (510) 625-6262 | Duoc T Nguyen, MD 3400 Delta Fair Blvd, Antioch, CA 94509-4004 Ph: (925) 779-5000 |
News Archive
A team led by a University of Arizona researcher has discovered a previously unknown mechanism that prevents the immune system from going into overdrive, shedding light not only on how our body controls its response to pathogens but on conditions such as autoimmune diseases, allergies and chronic inflammation as well.
Following today's introduction of a health care reform plan by Senate Finance Committee Chairman Max Baucus (D-MT), Joe Jackson, chairman of Save Flexible Spending Plans and CEO of WageWorks, a benefits company based in San Mateo, California, issued the following statement:
A new survey released today by the American Pain Foundation (APF) reveals that breakthrough cancer pain — sudden, temporary flares of severe pain that occur even when pain medication is used — is one of the most challenging aspects of having cancer, according to three out of four (75 percent) U.S. adults who have ever been diagnosed with cancer and experience this type of pain.
By analyzing the molecular details of how artificially created drug-resistant flu strains manage to survive treatment, St. Jude Children's Research Hospital scientists have developed insights to guide development of powerful new anti-influenza drugs. These compounds will target a viral enzyme critical to the virus' proliferation in the body.
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health. The experimental agent, known as AR-42 while in testing, was developed and tested in preclinical studies at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
› Verified 9 days ago
Kathleen A Regacho, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3901 Lone Tree Way, Antioch, CA 94509 Phone: 925-779-3522 | |
Khanh D Nguyen, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3901 Lone Tree Way, Antioch, CA 94509 Phone: 510-350-2657 | |
Mary Antionette Fitzsimons, M.D Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3901 Lone Tree Way, Antioch, CA 94509 Phone: 925-779-7273 | |
Raj V. Dasari, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3400 Delta Fair Blvd, Antioch, CA 94509 Phone: 925-779-5000 | |
Ivan S. Cavaliere, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3400 Delta Fair Blvd, Antioch, CA 94509 Phone: 925-779-5000 | |
Russell Gerald Rodriguez, M.D Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3901 Lone Tree Way, Antioch, CA 94509 Phone: 925-779-7273 | |
Susan Woodmansee, M.D Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3901 Lone Tree Way, Antioch, CA 94509 Phone: 925-779-7273 |